My Pump Blog

Medtronic Special Offer – please click “here” for further details on this amazing offer.

The MiniMed® VeoTM is now the ONLY system clinically proven to significantly reduce hypoglycaemic events: The evidence-

Summary

Two studies assessed the effect of Sensor Augmented Pump therapy (SAP) vs. SAP therapy with Low Glucose Suspend.

Results:

· 32% reduction in night time hypos1
· 38% less severity and duration of night time hypos1
· 40% less values in the hypo range at night1
· 0 severe hypos2

Conclusion: If we are going to one day close the loop we need to help more people with type 1 diabetes to gain access to Sensor Augmented Pump’s with automated suspend features.

Thanks again for reading.